Subject(s)

Epstein-Barr Virus Infections/therapy , Hematopoietic Stem Cell Transplantation , Immunotherapy, Adoptive , Lymphoproliferative Disorders/therapy , Paraproteinemias/therapy , Postoperative Complications/therapy , T-Lymphocytes, Cytotoxic/transplantation , Viremia/therapy , Blood Viscosity , Clone Cells/chemistry , Clone Cells/virology , Combined Modality Therapy , Female , Hematopoietic Stem Cell Transplantation/adverse effects , Herpesvirus 4, Human/immunology , Herpesvirus 4, Human/isolation & purification , Humans , Immunocompromised Host , Immunoglobulin M/blood , Immunosuppressive Agents/adverse effects , Lymphoproliferative Disorders/etiology , Lymphoproliferative Disorders/virology , Neoplastic Stem Cells/chemistry , Neoplastic Stem Cells/virology , Paraproteinemias/etiology , Paraproteinemias/virology , Paraproteins/analysis , Plasma Cells/chemistry , Plasma Cells/virology , Plasmapheresis , Remission Induction , T-Cell Antigen Receptor Specificity , T-Lymphocytes, Cytotoxic/immunology , Transplantation Conditioning/adverse effects , Viremia/etiology , Virus Activation , Young Adult

Subject(s)

Immunotherapy, Adoptive/adverse effects , Lymphoma/etiology , Receptors, Antigen, T-Cell/therapeutic use , Adult , Aged , DNA Transposable Elements , Female , Hematopoietic Stem Cell Transplantation , Humans , Immunotherapy, Adoptive/methods , Leukemia, B-Cell/genetics , Leukemia, B-Cell/therapy , Lymphoma/genetics , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/therapy , Male , Middle Aged , Receptors, Antigen, T-Cell/genetics , Treatment Outcome , Young Adult